✦ LIBER ✦

PUK11 UPDATED ECONOMIC ANALYSIS OF FESOTERODINE RELATIVE TO TOLTERODINE AND SOLIFENACIN FOR THE TREATMENT OF OVERACTIVE BLADDER: THE SWEDISH PERSPECTIVE

✍ Scribed by R. Lee; S.J. Snedecor; M.G. Kvasz; J. Trocio; B. Borgman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PUK20 A COST EFFECTIVENESS ANALYSIS OF S

✍ HH Kang; JY Bae; SY Park; HS Sohn 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PUK11 A COST-UTILITY ANALYSIS OF SOLIFEN

✍ L Cardozo; A Thorpe; M Grishchenko; MK Sidhu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

PUK8 A REVIEW: DIFFERING COSTS AND EFFEC

✍ SJ Snedecor; MF Botteman; D Weinstein; J Trocio 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

Comparison of fesoterodine and tolterodi

✍ Sender Herschorn; Steven Swift; Zhonghong Guan; Martin Carlsson; Jon D. Morrow; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 537 KB

PUK12 A COST-UTILITY ANALYSIS OF SOLIFEN

✍ L Cardozo; A Thorpe; M Grishchenko; MK Sidhu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB